JPMORGAN CHASE & CO - 30 Sep 2025 SCHEDULE 13G/A Report for Karyopharm Therapeutics Inc. Common Stock, $0.0001 par value (KPTI)

Filing Manager: JPMORGAN CHASE & CO
Reporting Manager: JPMORGAN CHASE & CO.
Security: Karyopharm Therapeutics Inc. Common Stock, $0.0001 par value
Symbol: KPTI
Shares outstanding: 8.73M shares
Disclosed Ownership: 428K shares
Ownership: 4.9%
Form type: SCHEDULE 13G/A
Filing time: 17 Oct 2025, 13:55:35 UTC
Date of event: 30 Sep 2025
Previous filing: 16 Jul 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
JPMORGAN CHASE & CO.	4.9%	428K	428K	0	Rachel Tsvaygoft	Vice President